Investigator Initated Trials (IIT)
•Download as PPS, PDF•
6 likes•7,848 views
The Industry funded IIT from the CRO perspective: Optimizing the interface between the industry and the Sponsor- Investigator. Presented by Ran Frenkel, CEO, Pharma Focus Israel at the First European Investigator Initiated Trials Conference in Barcelona, Spain.
Report
Share
Report
Share
![Main Discussion Points ,[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Investigator initiated trials (ExL Conference April-2012)
This document discusses investigator-initiated trials (IITs) and the roles and responsibilities of companies that provide funding and/or study drugs for IITs. It notes that companies should not lead the design or outcomes of IITs, but can review protocols to ensure scientific soundness and safety. It warns of potential legal issues if funding is perceived as a kickback or aimed at encouraging off-label use. The document provides recommendations for effective IIT program planning and communication with investigators.
Project management in clinical research sanjay akhani 8 may
This document discusses project management in clinical research. It begins with a disclaimer from the presenter. It then provides an overview of key aspects of project management in clinical research, including project management tools and techniques used, components of a project management plan, managing contract research organizations and site management organizations, optimizing patient recruitment, and working with remote and multicultural teams. Challenges of working with remote and multicultural teams include differences in communication styles, work ethics, decision making, and views of time and change due to cultural differences between high and low context cultures.
Audit in Pharmacovigilance
This document discusses pharmacovigilance risk management audits. It defines an audit and explains why pharmacovigilance system audits are performed. It describes different types of audits, including global pharmacovigilance system audits, company affiliate audits, and marketing partner audits. It also outlines audit scheduling, fundamentals, reporting, corrective actions, follow-up, metrics, and inspection readiness best practices. The overall purpose of pharmacovigilance audits is to ensure compliance and patient safety.
ich gcp principles
This document outlines the principles of ICH GCP and the role of institutional review boards (IRBs) and independent ethics committees (IECs) in clinical trials. It discusses that clinical trials should be scientifically sound and protect subject safety, rights, and well-being. IRBs/IECs are responsible for reviewing trials and documents like protocols, consent forms and investigator qualifications to ensure these principles are followed. They must provide approval or disapproval of trials in writing and conduct continuing oversight, while maintaining independence from trial sponsors and investigators. The composition, functions, operations and review procedures of IRBs/IECs are also described.
Clinical trials flow process
This document discusses the clinical trials process from protocol development through study completion. It covers developing the protocol, regulatory documents, patient recruitment, safety reporting, interim reports, and end of study activities. Key aspects include writing an approvable protocol, establishing an investigator site file, screening and enrolling suitable patients, maintaining safety oversight, and conducting closeout procedures. The goal is to provide guidance on managing all stages of a clinical trial.
eTMF ppt
An eTMF is an electronic system for organizing and storing documents related to clinical trials. It replaces paper regulatory binders with electronic storage in a computer server or cloud. Key benefits include increased compliance, efficiency, transparency, and cost savings compared to paper-based systems. While adoption of eTMFs is growing, challenges remain around scope, performance for large document volumes, and change management for training users.
Safety Reports: PBRER / PSUR
The aim of Safety reports is describe the safety during the lifecycle of the medicinal product. These reports are necessary during development as well as during the authorization process or renewal. In addition, several of these reports may be required by Health Authorities in case of safety concerns.
This presentation contains a full overview about periodic safety update reports and all the information related with it.
Monitoring and auditing in clinical trials
Monitoring and auditing are important quality control activities in clinical trials. Monitoring ensures accurate and compliant conduct of trials, while auditing independently evaluates trial conduct and compliance. Key aspects include:
Monitoring involves overseeing trial progress to ensure compliance. Monitors verify participant rights and data accuracy. Auditing independently examines trials and documents to determine GCP compliance. Audit findings help ensure future compliance. Together, monitoring and auditing protect participants and validate trial results.
Recommended
Investigator initiated trials (ExL Conference April-2012)
This document discusses investigator-initiated trials (IITs) and the roles and responsibilities of companies that provide funding and/or study drugs for IITs. It notes that companies should not lead the design or outcomes of IITs, but can review protocols to ensure scientific soundness and safety. It warns of potential legal issues if funding is perceived as a kickback or aimed at encouraging off-label use. The document provides recommendations for effective IIT program planning and communication with investigators.
Project management in clinical research sanjay akhani 8 may
This document discusses project management in clinical research. It begins with a disclaimer from the presenter. It then provides an overview of key aspects of project management in clinical research, including project management tools and techniques used, components of a project management plan, managing contract research organizations and site management organizations, optimizing patient recruitment, and working with remote and multicultural teams. Challenges of working with remote and multicultural teams include differences in communication styles, work ethics, decision making, and views of time and change due to cultural differences between high and low context cultures.
Audit in Pharmacovigilance
This document discusses pharmacovigilance risk management audits. It defines an audit and explains why pharmacovigilance system audits are performed. It describes different types of audits, including global pharmacovigilance system audits, company affiliate audits, and marketing partner audits. It also outlines audit scheduling, fundamentals, reporting, corrective actions, follow-up, metrics, and inspection readiness best practices. The overall purpose of pharmacovigilance audits is to ensure compliance and patient safety.
ich gcp principles
This document outlines the principles of ICH GCP and the role of institutional review boards (IRBs) and independent ethics committees (IECs) in clinical trials. It discusses that clinical trials should be scientifically sound and protect subject safety, rights, and well-being. IRBs/IECs are responsible for reviewing trials and documents like protocols, consent forms and investigator qualifications to ensure these principles are followed. They must provide approval or disapproval of trials in writing and conduct continuing oversight, while maintaining independence from trial sponsors and investigators. The composition, functions, operations and review procedures of IRBs/IECs are also described.
Clinical trials flow process
This document discusses the clinical trials process from protocol development through study completion. It covers developing the protocol, regulatory documents, patient recruitment, safety reporting, interim reports, and end of study activities. Key aspects include writing an approvable protocol, establishing an investigator site file, screening and enrolling suitable patients, maintaining safety oversight, and conducting closeout procedures. The goal is to provide guidance on managing all stages of a clinical trial.
eTMF ppt
An eTMF is an electronic system for organizing and storing documents related to clinical trials. It replaces paper regulatory binders with electronic storage in a computer server or cloud. Key benefits include increased compliance, efficiency, transparency, and cost savings compared to paper-based systems. While adoption of eTMFs is growing, challenges remain around scope, performance for large document volumes, and change management for training users.
Safety Reports: PBRER / PSUR
The aim of Safety reports is describe the safety during the lifecycle of the medicinal product. These reports are necessary during development as well as during the authorization process or renewal. In addition, several of these reports may be required by Health Authorities in case of safety concerns.
This presentation contains a full overview about periodic safety update reports and all the information related with it.
Monitoring and auditing in clinical trials
Monitoring and auditing are important quality control activities in clinical trials. Monitoring ensures accurate and compliant conduct of trials, while auditing independently evaluates trial conduct and compliance. Key aspects include:
Monitoring involves overseeing trial progress to ensure compliance. Monitors verify participant rights and data accuracy. Auditing independently examines trials and documents to determine GCP compliance. Audit findings help ensure future compliance. Together, monitoring and auditing protect participants and validate trial results.
How to report an SAE
This document provides guidance on reporting serious adverse events (SAEs) that occur during clinical trials in India. It outlines the key stakeholders involved in SAE reporting, including the investigator, sponsor/CRO, ethics committee, and Drug Controller General of India (DCGI). The timelines and process for initial and follow-up SAE reporting are defined. Requirements for the documents to be submitted in SAE reports, such as the checklist, case report form pages, and discharge summary, are also reviewed to ensure completeness and accuracy of the reports. Common errors made in SAE documentation are highlighted.
Adverse Events and Serious Adverse Events - Katalyst HLS
This document discusses adverse events and serious adverse events in clinical trials. It reviews FDA inspection findings related to reporting adverse events and the regulations surrounding adverse event reporting. It outlines how adverse events should be recorded, including source documentation and attribution. It also discusses reporting criteria and timelines for reporting adverse events to sponsors and regulatory bodies. Finally, it reviews considerations for auditing adverse events, such as whether events were properly graded and reported.
Overview on randomized control trial
Randomized controlled trials (RCTs) aim to reduce bias when testing new treatments by randomly allocating participants to either a treatment group or a control group. Random allocation means each participant has an equal probability of being assigned to either group. RCTs can be classified based on their design, such as parallel-group trials where each participant receives either the treatment or control. Blinding of participants and researchers is important to reduce biases. Allocation concealment, such as using opaque sealed envelopes, also helps reduce biases in RCT outcomes.
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...
In this presentation, we explore the TMF fundamentals and an introduction to better managing your TMF. We'll start by diving into the world of TMF management, how to properly leverage the regulations, which documents constitute as TMF-worthy and what basic metrics you can track to increase the efficiency of your trial.
Finally, we will also discuss some of the features Montrium has developed to facilitate the management of the Trial Master File in a fundamental way.
This presentation covers the following topics:
-Fundamentals of TMF management process
-How to use the regulations to ensure success
-What cross functional groups hold TMF worthy documents
-TMF management challenges and how you can alleviate them
-Base metrics to track and what they mean to your organization
-How an eTMF helps TMF Management
You can follow along with this presentation via our webinar:
https://info.montrium.com/tmf-fundamentals-an-introduction-to-better-trial-master-file-management
Patient recruitment
Patient recruitment and retention in clinical trials is recognized as a major challenge. Over 80% of trials fail to enroll on time due to difficulties recruiting the required number of suitable patients. Recruitment strategies are often not considered early enough in the trial planning process. Effective recruitment requires realistic timelines, adequate budgets, and the use of multiple recruitment methods like investigator databases, clinician referrals, advertisements, and community outreach. Maintaining open communication with patients and providing convenience are important for retention. Recent approaches to improve recruitment include using professional recruitment providers, market research, informatics, and centralized recruiting systems.
Audits & Inspections in Clinical Research
Explains about the basic concepts of Audits and Inspections in Clinical trials and various factors associated along with that.
ICH GCP
The document provides an overview of ICH GCP (International Council for Harmonisation Good Clinical Practice) guidelines. ICH GCP guidelines were developed to harmonize clinical trial standards and processes across regions. They establish international ethical and scientific quality standards for designing, conducting, and reporting clinical research involving human subjects. Adherence to ICH GCP provides public assurance that the rights, safety, and well-being of clinical trial subjects are protected.
Pharmacovigilance Audit
An audit is an official inspection done by an independent body to evaluate processes and ensure they comply with regulatory standards. Audits of pharmacovigilance systems are important to ensure patient safety, identify risks for improvement, and maintain compliance. The audit process involves planning, conducting interviews and documentation reviews, reporting findings, developing corrective actions, and following up to ensure issues are addressed. Being prepared for audits at all times is important for pharmacovigilance systems.
The Pharmacovigilance Audit Checklist - April 2013
If you are involved with Pharmacovigilance Audits or GPvP, you need to read this.
We also offer online courses for GPvP.. ask me for more details manish.kainth@infonetica.net
Ethical Considerations In Clinical Trials
The document discusses various ethical considerations in clinical trials, including planning trials, conducting research ethically, analyzing and reporting results, and ensuring justice. It provides an overview of guidelines for ethical clinical practice and considers issues like informed consent, minimizing risks and benefits, and equitable participant selection. Ensuring ethical research requires following principles like transparency, minimizing harm, and respecting participants' autonomy and welfare.
Anjali icmr ppt
The document summarizes the revised National Ethical Guidelines for Biomedical and Health Research involving Human Participants released by the Indian Council of Medical Research (ICMR) in 2017.
It provides an overview of the history and development of ethical guidelines in India and internationally. The key sections and principles covered in the new guidelines are summarized, including informed consent process, vulnerable groups, responsible conduct of research, and ethical review procedures. The guidelines aim to protect dignity, rights, safety and well-being of research participants according to core ethical principles of respect for persons, beneficence, non-maleficence and justice.
Insurance & compensation in clinical trial
PPT on insurance and compensation in clinical trial. Compensation formula. compensation guidelines, clinical trial related injury, SAE, serious adverse event, reporting of SAE and its timeline, compensation guidelines and formula for calculating the compensation
roles and responsibilities of Investigator[663]
The document discusses the roles and responsibilities of investigators in clinical trials. It states that the principal investigator is responsible for leading the clinical trial team at a trial site and ensuring proper conduct of the trial. Key responsibilities include being qualified to conduct the trial, obtaining necessary approvals, following good clinical practice guidelines, properly storing and using investigational products, obtaining informed consent, adhering to the protocol, maintaining accurate records, and communicating with regulatory bodies and the institutional review board. The investigator must ensure patient safety and welfare, medical care for participants, and protection of participant rights and confidentiality.
ICH GCP
The document discusses the International Conference on Harmonization (ICH) Good Clinical Practice (GCP) guideline.
ICH-GCP is an international ethical and scientific quality standard for clinical trials involving human subjects. It aims to ensure trials are scientifically sound and respect the rights, safety and well-being of participants. The guideline was developed in response to medical tragedies and the need for harmonized standards across regions to facilitate global drug development. It outlines principles for conducting clinical trials, including obtaining informed consent and ensuring confidentiality. Adherence to ICH-GCP provides assurance that clinical trial data are credible and that participants are adequately protected.
Clinical trial process
The clinical trial process involves planning, implementing, and analyzing clinical studies. The planning stage includes developing the study protocol and case report forms, designing the database, selecting study sites, and obtaining regulatory approval. During implementation, sites are activated, patients are screened and enrolled, data is collected and entered, and the database is locked. In the analysis stage, statistical analysis is conducted according to the analysis plan and clinical study reports are generated for regulatory submission. The goal is to carefully plan and implement the study to generate high quality data that can be accurately analyzed to draw clear conclusions.
PSUR Requirements
Requirements for PSURs in accordance with Vol.9A of The Rules Governing Medicinal Products for Human Use and EMA's position
Contract research
This document discusses Contract Research Organizations (CROs) and their role in supporting the pharmaceutical industry. It provides information on:
- What CROs are and the services they offer pharmaceutical companies, such as conducting clinical trials.
- Best practices for pharmaceutical companies when partnering with CROs, including clearly defining study specifications, selecting the right CRO based on capability and cost, and managing the relationship.
- Key aspects of contracts between sponsors and CROs such as defining roles and responsibilities, compliance with regulations, intellectual property, and termination policies.
The document aims to provide guidance to pharmaceutical companies on effectively partnering with CROs for outsourced drug development activities.
Explaining the Importance of Feasibility Questionnaires and Site Selection Vi...
No matter if you’re reading this because you aspire to become a CRA, or you’re a study coordinator, or maybe you’re part of a research site, learning about feasibility surveys and questionnaires is important for everyone that’s in any way involved in clinical trials.
In this article, we’ll try to explain to you why feasibility questionnaires and site selection visits are important and how they can affect the sponsor’s decision of awarding you the study.
Pharmacovigilance Inspections
Raj Bhogal, Head of Regulatory Inspections, R&D Quality Takeda on the topic of 'Pharmacovigilance Inspections' at IFAH held at Le Meridien, Dubai on 16th - 18th December, 2019.
Understanding Contracts in the Clinical Research Process
Presentation on key aspects of clinical trial agreements, with an emphasis on clauses impacting indemnification, confidentiality, material transfers, record retention, ownership of data,
Iis risk-responsibilities-rewards
This document discusses investigator initiated research (IIR), including the risks, responsibilities, and potential rewards. It notes that spending on IIR has been increasing faster than clinical trials. IIR must be carefully monitored to ensure the research is legitimate. The document outlines various considerations for managing the risks of IIR, such as clearly defining roles and responsibilities. It emphasizes the importance of planning IIR properly through protocols, oversight, infrastructure reviews, and contracts. Investigators are responsible for following their plans, recording conduct, and reporting on their research. When done correctly, IIR can promote innovation and expand medical knowledge.
Highlights from ExL Pharma's Proactive GCP Compliance
This document summarizes a conference on Good Clinical Practice (GCP) compliance. It discusses the objectives of clinical research and challenges to harmonizing GCP standards internationally. It also outlines current ethical challenges in clinical trials and dimensions of GCP frameworks. The document proposes that further developing national and regional GCP guidance, broadening the scope of GCP, and establishing appropriate platforms can help advance GCP. It provides guidance on investigator responsibilities and comments on adverse event reporting.
More Related Content
What's hot
How to report an SAE
This document provides guidance on reporting serious adverse events (SAEs) that occur during clinical trials in India. It outlines the key stakeholders involved in SAE reporting, including the investigator, sponsor/CRO, ethics committee, and Drug Controller General of India (DCGI). The timelines and process for initial and follow-up SAE reporting are defined. Requirements for the documents to be submitted in SAE reports, such as the checklist, case report form pages, and discharge summary, are also reviewed to ensure completeness and accuracy of the reports. Common errors made in SAE documentation are highlighted.
Adverse Events and Serious Adverse Events - Katalyst HLS
This document discusses adverse events and serious adverse events in clinical trials. It reviews FDA inspection findings related to reporting adverse events and the regulations surrounding adverse event reporting. It outlines how adverse events should be recorded, including source documentation and attribution. It also discusses reporting criteria and timelines for reporting adverse events to sponsors and regulatory bodies. Finally, it reviews considerations for auditing adverse events, such as whether events were properly graded and reported.
Overview on randomized control trial
Randomized controlled trials (RCTs) aim to reduce bias when testing new treatments by randomly allocating participants to either a treatment group or a control group. Random allocation means each participant has an equal probability of being assigned to either group. RCTs can be classified based on their design, such as parallel-group trials where each participant receives either the treatment or control. Blinding of participants and researchers is important to reduce biases. Allocation concealment, such as using opaque sealed envelopes, also helps reduce biases in RCT outcomes.
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...
In this presentation, we explore the TMF fundamentals and an introduction to better managing your TMF. We'll start by diving into the world of TMF management, how to properly leverage the regulations, which documents constitute as TMF-worthy and what basic metrics you can track to increase the efficiency of your trial.
Finally, we will also discuss some of the features Montrium has developed to facilitate the management of the Trial Master File in a fundamental way.
This presentation covers the following topics:
-Fundamentals of TMF management process
-How to use the regulations to ensure success
-What cross functional groups hold TMF worthy documents
-TMF management challenges and how you can alleviate them
-Base metrics to track and what they mean to your organization
-How an eTMF helps TMF Management
You can follow along with this presentation via our webinar:
https://info.montrium.com/tmf-fundamentals-an-introduction-to-better-trial-master-file-management
Patient recruitment
Patient recruitment and retention in clinical trials is recognized as a major challenge. Over 80% of trials fail to enroll on time due to difficulties recruiting the required number of suitable patients. Recruitment strategies are often not considered early enough in the trial planning process. Effective recruitment requires realistic timelines, adequate budgets, and the use of multiple recruitment methods like investigator databases, clinician referrals, advertisements, and community outreach. Maintaining open communication with patients and providing convenience are important for retention. Recent approaches to improve recruitment include using professional recruitment providers, market research, informatics, and centralized recruiting systems.
Audits & Inspections in Clinical Research
Explains about the basic concepts of Audits and Inspections in Clinical trials and various factors associated along with that.
ICH GCP
The document provides an overview of ICH GCP (International Council for Harmonisation Good Clinical Practice) guidelines. ICH GCP guidelines were developed to harmonize clinical trial standards and processes across regions. They establish international ethical and scientific quality standards for designing, conducting, and reporting clinical research involving human subjects. Adherence to ICH GCP provides public assurance that the rights, safety, and well-being of clinical trial subjects are protected.
Pharmacovigilance Audit
An audit is an official inspection done by an independent body to evaluate processes and ensure they comply with regulatory standards. Audits of pharmacovigilance systems are important to ensure patient safety, identify risks for improvement, and maintain compliance. The audit process involves planning, conducting interviews and documentation reviews, reporting findings, developing corrective actions, and following up to ensure issues are addressed. Being prepared for audits at all times is important for pharmacovigilance systems.
The Pharmacovigilance Audit Checklist - April 2013
If you are involved with Pharmacovigilance Audits or GPvP, you need to read this.
We also offer online courses for GPvP.. ask me for more details manish.kainth@infonetica.net
Ethical Considerations In Clinical Trials
The document discusses various ethical considerations in clinical trials, including planning trials, conducting research ethically, analyzing and reporting results, and ensuring justice. It provides an overview of guidelines for ethical clinical practice and considers issues like informed consent, minimizing risks and benefits, and equitable participant selection. Ensuring ethical research requires following principles like transparency, minimizing harm, and respecting participants' autonomy and welfare.
Anjali icmr ppt
The document summarizes the revised National Ethical Guidelines for Biomedical and Health Research involving Human Participants released by the Indian Council of Medical Research (ICMR) in 2017.
It provides an overview of the history and development of ethical guidelines in India and internationally. The key sections and principles covered in the new guidelines are summarized, including informed consent process, vulnerable groups, responsible conduct of research, and ethical review procedures. The guidelines aim to protect dignity, rights, safety and well-being of research participants according to core ethical principles of respect for persons, beneficence, non-maleficence and justice.
Insurance & compensation in clinical trial
PPT on insurance and compensation in clinical trial. Compensation formula. compensation guidelines, clinical trial related injury, SAE, serious adverse event, reporting of SAE and its timeline, compensation guidelines and formula for calculating the compensation
roles and responsibilities of Investigator[663]
The document discusses the roles and responsibilities of investigators in clinical trials. It states that the principal investigator is responsible for leading the clinical trial team at a trial site and ensuring proper conduct of the trial. Key responsibilities include being qualified to conduct the trial, obtaining necessary approvals, following good clinical practice guidelines, properly storing and using investigational products, obtaining informed consent, adhering to the protocol, maintaining accurate records, and communicating with regulatory bodies and the institutional review board. The investigator must ensure patient safety and welfare, medical care for participants, and protection of participant rights and confidentiality.
ICH GCP
The document discusses the International Conference on Harmonization (ICH) Good Clinical Practice (GCP) guideline.
ICH-GCP is an international ethical and scientific quality standard for clinical trials involving human subjects. It aims to ensure trials are scientifically sound and respect the rights, safety and well-being of participants. The guideline was developed in response to medical tragedies and the need for harmonized standards across regions to facilitate global drug development. It outlines principles for conducting clinical trials, including obtaining informed consent and ensuring confidentiality. Adherence to ICH-GCP provides assurance that clinical trial data are credible and that participants are adequately protected.
Clinical trial process
The clinical trial process involves planning, implementing, and analyzing clinical studies. The planning stage includes developing the study protocol and case report forms, designing the database, selecting study sites, and obtaining regulatory approval. During implementation, sites are activated, patients are screened and enrolled, data is collected and entered, and the database is locked. In the analysis stage, statistical analysis is conducted according to the analysis plan and clinical study reports are generated for regulatory submission. The goal is to carefully plan and implement the study to generate high quality data that can be accurately analyzed to draw clear conclusions.
PSUR Requirements
Requirements for PSURs in accordance with Vol.9A of The Rules Governing Medicinal Products for Human Use and EMA's position
Contract research
This document discusses Contract Research Organizations (CROs) and their role in supporting the pharmaceutical industry. It provides information on:
- What CROs are and the services they offer pharmaceutical companies, such as conducting clinical trials.
- Best practices for pharmaceutical companies when partnering with CROs, including clearly defining study specifications, selecting the right CRO based on capability and cost, and managing the relationship.
- Key aspects of contracts between sponsors and CROs such as defining roles and responsibilities, compliance with regulations, intellectual property, and termination policies.
The document aims to provide guidance to pharmaceutical companies on effectively partnering with CROs for outsourced drug development activities.
Explaining the Importance of Feasibility Questionnaires and Site Selection Vi...
No matter if you’re reading this because you aspire to become a CRA, or you’re a study coordinator, or maybe you’re part of a research site, learning about feasibility surveys and questionnaires is important for everyone that’s in any way involved in clinical trials.
In this article, we’ll try to explain to you why feasibility questionnaires and site selection visits are important and how they can affect the sponsor’s decision of awarding you the study.
Pharmacovigilance Inspections
Raj Bhogal, Head of Regulatory Inspections, R&D Quality Takeda on the topic of 'Pharmacovigilance Inspections' at IFAH held at Le Meridien, Dubai on 16th - 18th December, 2019.
Understanding Contracts in the Clinical Research Process
Presentation on key aspects of clinical trial agreements, with an emphasis on clauses impacting indemnification, confidentiality, material transfers, record retention, ownership of data,
What's hot (20)
Adverse Events and Serious Adverse Events - Katalyst HLS
Adverse Events and Serious Adverse Events - Katalyst HLS
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...
The Pharmacovigilance Audit Checklist - April 2013
The Pharmacovigilance Audit Checklist - April 2013
Explaining the Importance of Feasibility Questionnaires and Site Selection Vi...
Explaining the Importance of Feasibility Questionnaires and Site Selection Vi...
Understanding Contracts in the Clinical Research Process
Understanding Contracts in the Clinical Research Process
Similar to Investigator Initated Trials (IIT)
Iis risk-responsibilities-rewards
This document discusses investigator initiated research (IIR), including the risks, responsibilities, and potential rewards. It notes that spending on IIR has been increasing faster than clinical trials. IIR must be carefully monitored to ensure the research is legitimate. The document outlines various considerations for managing the risks of IIR, such as clearly defining roles and responsibilities. It emphasizes the importance of planning IIR properly through protocols, oversight, infrastructure reviews, and contracts. Investigators are responsible for following their plans, recording conduct, and reporting on their research. When done correctly, IIR can promote innovation and expand medical knowledge.
Highlights from ExL Pharma's Proactive GCP Compliance
This document summarizes a conference on Good Clinical Practice (GCP) compliance. It discusses the objectives of clinical research and challenges to harmonizing GCP standards internationally. It also outlines current ethical challenges in clinical trials and dimensions of GCP frameworks. The document proposes that further developing national and regional GCP guidance, broadening the scope of GCP, and establishing appropriate platforms can help advance GCP. It provides guidance on investigator responsibilities and comments on adverse event reporting.
Highlights from ExL Pharma's 4th Latin America Clinical Trials
This document summarizes presentations from ExLPharma's 4th Latin America Clinical Trials conference. It discusses topics like IRB collaboration between institutions, using microfinance organizations' infrastructure to aid in clinical trial recruitment and retention, ensuring quality in clinical research, and considerations for outsourcing clinical research functions. Key aspects covered include developing countries' IRB competencies, challenges and benefits of the clinical trial-microfinance partnership model, importance of quality oversight and planning, and factors to consider for outsourcing research and development activities.
0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocolsWorkgroup of European Cancer Patient Advocacy Networks
1) Drug development involves multiple phases of clinical trials in humans (phases I-IV) to test dosing, safety and efficacy in an increasing number of patients before regulatory approval and market access.
2) Patient involvement in clinical research is important to ensure trials address patient priorities and perspectives on risk/benefit, endpoints, and trial design elements like inclusion criteria.
3) Key elements of a clinical trial protocol include type of comparisons, randomization, blinding, endpoints, inclusion/exclusion criteria, schedule of events, informed consent process, and patient reported outcomes.Observational Studies: Strategic, Operational and Budgetary Considerations
Observational studies provide important real-world data on drug safety, effectiveness, and value that complement randomized controlled trials. However, conducting observational studies presents unique operational challenges and requires specialized skills different from traditional clinical trials. If properly designed and managed, observational studies can fulfill post-approval regulatory obligations in a cost-effective manner by generating real-world evidence on safety, clinical outcomes, economics, and patient experiences.
Challenges_ISR_IDSSFINAL
This document summarizes a presentation about challenges and experiences with multinational investigator-sponsored research (ISR) trials. It discusses the roles of investigators and sponsors in ISRs. It outlines key elements of a successful multinational ISR, including study design, infrastructure, site selection, and data analysis. Potential challenges include feasibility of treatment across countries, sample size, regulatory compliance, contractual issues, and limited resources. However, multinational ISRs also provide opportunities to expand medical knowledge through independent research and promote further studies.
Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...
Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...SC CTSI at USC and CHLA
Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Virtual, & Decentralized Clinical TrialsSPONSOR MONITORING
Sponsor monitoring in clinical research refers to the oversight and supervision conducted by the sponsor or sponsor's representative throughout the course of a clinical trial. The purpose of sponsor monitoring is to ensure the rights, safety, and well-being of study participants, as well as the quality and integrity of the trial data. Here are some key aspects and considerations related to sponsor monitoring in clinical research
Research and Best Practices
The document provides an overview of research best practices, including defining different types of research, methodologies, and tools used for analysis. It discusses primary and secondary research, qualitative and quantitative research, as well as exploratory, descriptive, and experimental research. Common analysis tools covered include Porter's Five Forces, PACE, PEST, BCG matrix, and cause-and-effect diagrams. The document also outlines career opportunities in knowledge process outsourcing and takes the perspective of advising an entrepreneur on entering the Indian mobile handset market.
PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Out...
PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Out...Patient-Centered Outcomes Research Institute
This document provides an overview and instructions for submitting a Letter of Intent (LOI) for the August 2013 cycle of funding announcements from the Patient-Centered Outcomes Research Institute (PCORI). It introduces PCORI's mission and funding areas, describes the Improving Methods for Conducting Patient-Centered Outcomes Research funding announcement, outlines the LOI submission process and requirements, and provides resources and dates for applicants. Representatives from PCORI are present to answer any questions about the LOI or application process.ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
The document discusses the ICH GCP guidelines for conducting clinical trials. The key points are:
1) GCP guidelines provide ethical and quality standards for clinical trial conduct to protect subject safety and ensure data credibility.
2) The guidelines establish responsibilities for investigators, sponsors, and ethics committees to follow principles where subject welfare prevails over science and trials must be scientifically sound.
3) The ICH facilitates harmonization across countries/regions to streamline drug development and avoid duplicative trials through consensus guidelines.
Acrp Presentation Jan 2009
This document discusses the relationship between academia and industry in clinical research. It outlines both the benefits and challenges of the relationship from both perspectives. Industry benefits from access to academic institutions' scientific and clinical expertise. Academia benefits from industry's funding and ability to conduct large clinical trials. However, challenges include navigating academic bureaucracies, negotiating contracts and budgets, and balancing industry's profit motives with academia's focus on research. The document proposes ways to improve the relationship, such as streamlining processes and improving communication between partners.
Highlights from ExL Pharma's 12th Investigator Initiated Trials
- ExLPharma holds annual conferences on investigator-initiated trials (IITs) to discuss governance models, planning, operations, and the role of medical science liaisons (MSLs).
- Key topics included developing a review committee and charter, strategic planning documents, budgeting, standard operating procedures, and metrics to measure program success.
- The role of MSLs in IITs is to provide scientific feedback, study information, and liaise across functions like medical information and clinical development to support investigators.
- Prioritizing IITs involves aligning them with product strategies and evaluating proposals based on strategic fit, scientific design, and investigator/site capabilities.
Clinical trial recruitment overview
- Patient recruitment for clinical trials is a major challenge, estimated to be a $1.2-1.8 billion market. Recruitment costs average 6% of trial costs and are a primary factor in delays.
- Less than 5% of patients are aware of clinical trials, and only 2-3% actually enroll. However, over 90% of participants have a positive experience and would participate again.
- There is significant opportunity to improve recruitment through more patient-centric approaches leveraging data, technology, and analytics to identify more eligible patients and improve the recruitment process. However, this will require changes to traditional models.
Career in clinical research
Want to do career in clinical research? Know more about the career opportunities in clinical research at Academy for Clinical Excellence (ACE).
An Introduction To Compliance Program
The document discusses the importance and benefits of implementing an effective compliance program at a health care organization. It outlines the key elements that should be included in a comprehensive compliance program, such as policies and procedures, oversight, education and training, auditing, reporting, and enforcement. An effective compliance program can help communicate an organization's commitment to ethics, prevent fines and penalties, and protect from liability. It is essential for health care providers to follow guidelines from the Office of Inspector General.
Current Trends in Data Protection for Integrated Health, Centralized Peer Rev...
A webinar hosted by PYA and the Alliance for Quality Improvement (AQIPS) explored “Current Trends in Data Protection for Integrated Health, Centralized Peer Review Systems, and Other Innovative Programs.” PYA Principal Martie Ross participated in the webinar, which focused on how patient safety organization (PSO) protections can bring value to accountable care organizations and other integrated health systems.
In addition, the webinar provided instruction for using:
Patient Safety and Quality Improvement Act (PSQIA) protections in Medicare Shared Savings Programs, centralized peer review programs, and other collaboratives.
PSQIA protections for new types of clinical analysis, clinical quality reports, and performance tools that contain information that may not be protected under existing state peer review privilege or are shared among an integrated network.
Safety & Regulatory Solutions for Small and Medium-sized Life Science Organiz...
Small- and medium-sized life science companies face challenges in efficiently managing safety and regulatory activities across their clinical trials and post-marketing processes due to limited resources. Outsourcing some functions can help optimize resource utilization. Specialized clinical research organizations and functional service providers can take responsibility for activities like safety monitoring, pharmacovigilance, and regulatory submissions to ensure compliance and allow companies to focus on core tasks. An integrated, flexible outsourcing model provides domain expertise, processes, and technology to deliver high-quality, compliant operations and help companies efficiently develop and market new medicines.
Vendor Management - Compliance Checklist Manifesto Series
Regulatory examiners are expecting to see and review your financial institution's vendor management program, which is to include a process for assessing specific vendor risk, vendor selection, contracting, and ongoing oversight. This webinar will demonstrate that implementing a repeatable process will provide consistency and reduce your institution's Compliance Tax by saving you time and resources, including helping to ensure your valuable dollars are spent wisely.
Objectives:
- Understanding of the regulatory requirements for the vendor management program
- High level overview of the key elements
- Provide guidance in developing your program
Research Partnerships to Support Telehealth Opportunities
This document discusses potential opportunities for research partnerships between universities and industry in the area of telehealth. It outlines several types of partnerships that could be pursued, including technology research and development, evaluations of telehealth solutions, pilots and clinical trials, and university involvement in product development. It also discusses how such partnerships could provide funding for researchers, intellectual property licensing arrangements, and various federal and state funding programs that support commercialization collaborations.
Similar to Investigator Initated Trials (IIT) (20)
Highlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical Trials
0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols
Observational Studies: Strategic, Operational and Budgetary Considerations
Observational Studies: Strategic, Operational and Budgetary Considerations
Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...
Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...
PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Out...
PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Out...
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Current Trends in Data Protection for Integrated Health, Centralized Peer Rev...
Current Trends in Data Protection for Integrated Health, Centralized Peer Rev...
Safety & Regulatory Solutions for Small and Medium-sized Life Science Organiz...
Safety & Regulatory Solutions for Small and Medium-sized Life Science Organiz...
Vendor Management - Compliance Checklist Manifesto Series
Vendor Management - Compliance Checklist Manifesto Series
Research Partnerships to Support Telehealth Opportunities
Research Partnerships to Support Telehealth Opportunities
Recently uploaded
Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Stone Art Hub offers the best competitive Marble Pricing in Dubai, ensuring affordability without compromising quality. With a wide range of exquisite marble options to choose from, you can enhance your spaces with elegance and sophistication. For inquiries or orders, contact us at ☎ 9928909666. Experience luxury at unbeatable prices.
Part 2 Deep Dive: Navigating the 2024 Slowdown
Introduction
The global retail industry has weathered numerous storms, with the financial crisis of 2008 serving as a poignant reminder of the sector's resilience and adaptability. However, as we navigate the complex landscape of 2024, retailers face a unique set of challenges that demand innovative strategies and a fundamental shift in mindset. This white paper contrasts the impact of the 2008 recession on the retail sector with the current headwinds retailers are grappling with, while offering a comprehensive roadmap for success in this new paradigm.
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
IMPACT Silver is a pure silver zinc producer with over $260 million in revenue since 2008 and a large 100% owned 210km Mexico land package - 2024 catalysts includes new 14% grade zinc Plomosas mine and 20,000m of fully funded exploration drilling.
一比一原版(QMUE毕业证书)英国爱丁堡玛格丽特女王大学毕业证文凭如何办理
永久可查学历认证【微信：A575476】【(QMUE毕业证书)英国爱丁堡玛格丽特女王大学毕业证成绩单Offer】【微信：A575476】（留信学历认证永久存档查询）采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信：A575476】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信：A575476】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
→ 【关于价格问题（保证一手价格）
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
选择实体注册公司办理，更放心，更安全！我们的承诺：可来公司面谈，可签订合同，会陪同客户一起到教育部认证窗口递交认证材料，客户在教育部官方认证查询网站查询到认证通过结果后付款，不成功不收费！
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...❼❷⓿❺❻❷❽❷❼❽ Dpboss Kalyan Satta Matka Guessing Matka Result Main Bazar chart
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Final ank Satta Matka Dpbos Final ank Satta Matta Matka 143 Kalyan Matka Guessing Final Matka Final ank Today Matka 420 Satta Batta Satta 143 Kalyan Chart Main Bazar Chart vip Matka Guessing Dpboss 143 Guessing Kalyan night Prescriptive analytics BA4206 Anna University PPT
Business analysis - Prescriptive analytics Introduction to Prescriptive analytics
Prescriptive Modeling
Non Linear Optimization
Demonstrating Business Performance Improvement
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
“After being the most listed dog breed in the United States for 31
years in a row, the Labrador Retriever has dropped to second place
in the American Kennel Club's annual survey of the country's most
popular canines. The French Bulldog is the new top dog in the
United States as of 2022. The stylish puppy has ascended the
rankings in rapid time despite having health concerns and limited
color choices.”
Industrial Tech SW: Category Renewal and Creation
Every industrial revolution has created a new set of categories and a new set of players.
Multiple new technologies have emerged, but Samsara and C3.ai are only two companies which have gone public so far.
Manufacturing startups constitute the largest pipeline share of unicorns and IPO candidates in the SF Bay Area, and software startups dominate in Germany.
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
Nathalie zal delen hoe DEI en ESG een fundamentele rol kunnen spelen in je merkstrategie en je de juiste aansluiting kan creëren met je doelgroep. Door middel van voorbeelden en simpele handvatten toont ze hoe dit in jouw organisatie toegepast kan worden.
Kirill Klip GEM Royalty TNR Gold Lithium Presentation
Lithium Will Power Us For The Next 50 Years And Then Robots: Kirill Klip GEM Royalty TNR Gold Lithium Presentation
欧洲杯投注-欧洲杯投注外围盘口-欧洲杯投注盘口app|【网址🎉ac22.net🎉】
【网址🎉ac22.net🎉】欧洲杯投注是体育博彩和在线赌场之一，得益于UKGC的三项许可。 成立之初是三名博彩公司将40家博彩商店的合并的结果，共同创建一家名为欧洲杯投注的公司。 欧洲杯投注在线赌场为游戏爱好者提供了300多种游戏，其中200多种老虎机，其他游戏包括二十一点，轮盘，真人荷官和真人赌场等。
DearbornMusic-KatherineJasperFullSailUni
My powerpoint presentation for my Music Retail and Distribution class at Full Sail University
Kirill Klip GEM Royalty TNR Gold Copper Presentation
Tesla Energy rEVolution And The Golden Age For Copper: Kirill Klip GEM Royalty TNR Gold Copper Presentation
The latest Heat Pump Manual from Newentide
𝐔𝐧𝐯𝐞𝐢𝐥 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐄𝐧𝐞𝐫𝐠𝐲 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐰𝐢𝐭𝐡 𝐍𝐄𝐖𝐍𝐓𝐈𝐃𝐄’𝐬 𝐋𝐚𝐭𝐞𝐬𝐭 𝐎𝐟𝐟𝐞𝐫𝐢𝐧𝐠𝐬
Explore the details in our newly released product manual, which showcases NEWNTIDE's advanced heat pump technologies. Delve into our energy-efficient and eco-friendly solutions tailored for diverse global markets.
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart➒➌➎➏➑➐➋➑➐➐Dpboss Matka Guessing Satta Matka Kalyan Chart Indian Matka
SATTA MATKA SATTA FAST RESULT KALYAN TOP MATKA RESULT KALYAN SATTA MATKA FAST RESULT MILAN RATAN RAJDHANI MAIN BAZAR MATKA FAST TIPS RESULT MATKA CHART JODI CHART PANEL CHART FREE FIX GAME SATTAMATKA ! MATKA MOBI SATTA 143 spboss.in TOP NO1 RESULT FULL RATE MATKA ONLINE GAME PLAY BY APP SPBOSSSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
Profiles of Iconic Fashion Personalities.pdf
The fashion industry is dynamic and ever-changing, continuously sculpted by trailblazing visionaries who challenge norms and redefine beauty. This document delves into the profiles of some of the most iconic fashion personalities whose impact has left a lasting impression on the industry. From timeless designers to modern-day influencers, each individual has uniquely woven their thread into the rich fabric of fashion history, contributing to its ongoing evolution.
Recently uploaded (20)
Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Best Competitive Marble Pricing in Dubai - ☎ 9928909666
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
Kirill Klip GEM Royalty TNR Gold Lithium Presentation
Kirill Klip GEM Royalty TNR Gold Lithium Presentation
Kirill Klip GEM Royalty TNR Gold Copper Presentation
Kirill Klip GEM Royalty TNR Gold Copper Presentation
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Investigator Initated Trials (IIT)
- 1. The Industry Sponsored IIT from the CRO perspective: Optimizing the interface between the industry and the sponsor-investigator Ran Frenkel, RPh CEO PFC Pharma Focus Israel www.pharmafocus.co.il European Investigator Initiated Trials October 30-31, 2008 Barcelona Spain
- 5. The IIT Position IIT IIT
- 11. The forces in IS-IIT
- 12. Marketing Authorization Holder (MAH)
- 32. Industry Sponsored Trials Investigator Initiated Trial Sponsor Sponsor Investigator Project Director Project Director Medical Monitor/Advisor Medical Monitor/Advisor Pharmacovigilance Project Manager IMP Data Management & Biostatistics CRO Laboratory Project Manager Pharmacovigilance CRA Study Team Data Management & Biostatistics Patients Central Laboratory Study Sites Principal Investigator & Study Team Patients
- 40. Other facets of complexity
- 41. Contract Research Organization (CRO)
- 46. Contract setup of multicenter IIT Local CRO IMP Packaging & Labeling IMP Manufacturer Vendor A Vendor B CRO Site 3 Sponsor Investigator Site 1 Site 2 Site 4
- 47. Inv. Fees Legal, Insurance Inv. Meeting MON, MM, DM Site support IMP
- 55. Reaching the balance point